Pharmaceutical Fill and Finish Outsourcing Market Report 2026

Pharmaceutical Fill and Finish Outsourcing Market Overview

• Pharmaceutical Fill and Finish Outsourcing market size has reached to $3.77 billion in 2025 • Expected to grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Biologic Drug Demand Drives Growth In Pharmaceutical Fill And Finish Outsourcing Market • Market Trend: Sustainable Packaging Innovations Drive Environmental Conservation In Pharmaceutical Fill And Finish Outsourcing Market • North America was the largest region in 2025.

What Is Covered Under Pharmaceutical Fill and Finish Outsourcing Market?

Pharmaceutical fill and finish outsourcing is the practice of contracting with specialized pharmaceutical manufacturing companies to offer pharmaceutical filling and sealing operations into end-use containers with appropriate sterility and accuracy. These services are utilized by pharmaceutical and biopharmaceutical companies for specialized people with experience, costly automated equipment acquisitions, stringent regulatory agency inspection, increased efficiency, and flexibility in terms of production capacity. The main types of pharmaceutical fill and finish outsourcing products are liquids, solids, and semi-solids. Liquid refers to a pharmaceutical formulation that is pourable and comprises a combination of active drug or chemical components and nondrug or inert components. These are processed from organic substances isolated from animal origin, organic substances isolated from microorganisms, and inorganic substances. These are utilized by pharmaceutical and biopharmaceutical companies.

What Is The Pharmaceutical Fill and Finish Outsourcing Market Growth Forecast?

The pharmaceutical fill and finish outsourcing market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing vaccine and biologics pipeline expansion, rising preference for scalable outsourcing models, growing investments in advanced aseptic technologies, expansion of personalized medicine production, increasing regulatory scrutiny on manufacturing quality. Major trends in the forecast period include increasing outsourcing of sterile fill and finish operations, rising demand for high-speed automated filling lines, expansion of single-use filling technologies, growing focus on regulatory compliance expertise, adoption of flexible manufacturing capacity models.

Global Pharmaceutical Fill and Finish Outsourcing Market Segmentation

1) By State Of Finished Products: Liquid, Solids, Semi Solids 2) By Content: Organic Substances Isolated From Animal Origin, Organic Substances Isolated From Microorganisms, Inorganic Substances 3) By End-Users: Biopharmaceutical Companies, Pharmaceutical Companies Subsegments: 1) By Liquid: Injectables, Solutions, Suspensions 2) By Solids: Tablets, Capsules, Powders 3) By Semi-Solids: Ointments, Creams, Gels

What Is The Driver Of The Pharmaceutical Fill and Finish Outsourcing Market?

The rising demand for biologic drugs is expected to propel the growth of the pharmaceutical fill and finish outsourcing market going forward. Biologic drugs, also known as biologics or biosimilars, are a class of pharmaceutical products derived from living organisms or containing components of living organisms. Drug manufacturers can use the skills and infrastructure of contract manufacturing organizations (CMOs) by outsourcing the fill and finish phase of production, allowing pharmaceutical companies to focus on the development, research, and scale-up of their biologic drugs while relying on CMOs for efficient and cost-effective fill and finish operations. For instance, in April 2025, Hardman and Co., a UK-based independent investment research and corporate advisory business company, reported that the U.S. Food and Drug Administration approved 63 new chemical entities and biologics in 2024, up from 53 in 2023. Therefore, the rising demand for biologic drugs will fill the pharmaceutical and finish the outsourcing market.

Key Players In The Global Pharmaceutical Fill and Finish Outsourcing Market

Major companies operating in the pharmaceutical fill and finish outsourcing market are Groninger and Co. GmbH, Wockhardt Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceuticals Industries Ltd., Recipharm AB, Lonza Group AG, Catalent Inc., Dr. Reddys Laboratories Ltd., West Pharmaceutical Services Inc., Sun Pharmaceutical Industries Ltd., Patheon N.V., Piramal Enterprises Ltd., Gerresheimer AG, CordenPharma International, Fujifilm Diosynth Biotechnologies, Optima Packaging Group GmbH, Jubilant HollisterStier LLC., Ajinomoto Bio-Pharma Services, Cytovance Biologics Inc., Grand River Aseptic Manufacturing, Baxter Pharmaceutical Solutions LLC., Halo Pharma Inc., MabPlex Inc., August Bioservices, Siegfried Holding AG, Aenova Group, SK Pharmteco, Recro Pharma

Global Pharmaceutical Fill and Finish Outsourcing Market Trends and Insights

Major companies operating in the pharmaceutical fill and finish outsourcing market are focusing on developing sustainable packaging materials and methods for reducing their carbon footprint and conserving the environment. Sustainable packaging refers to the development and use of packaging that minimizes its impact on the environment throughout its entire lifecycle. For instance, in November 2023, Amcor, an Australia-based pharmaceutical packaging company, launched next-generation Healthcare Recycle-Ready Medical Laminates. Amcor is creating all-film packaging that satisfies device application performance requirements while lowering the final package's carbon footprint and being recyclable in the polyethylene stream. A polyethylene (PE) laminate that is a monomaterial and suitable for a variety of packaging formats is the solution. It can be used to replace non-recyclable lidding for 3D thermoformed packages that aren't recyclable with recyclable lidding for items like drapes, protective materials, catheters, injections, and tubing systems.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Fill and Finish Outsourcing Market?

In January 2023, Life Science Outsourcing Inc., a US-based contract manufacturer and value-added service company, acquired J-Pac Medical for an undisclosed amount. The acquisition broadens service offerings, ensures manufacturing capacities, and grows into the biomaterials and diagnostics end markets. J-Pac Medical is a US-based medical device and diagnostic manufacturing and packaging outsourcing partner specializing in assembly, packing, sterilization, and diagnostics.

Regional Outlook

North America was the largest region in the pharmaceutical fill and finish outsourcing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Fill and Finish Outsourcing Market?

The pharmaceutical fill and finish outsourcing market includes revenues earned by entities by providing outsourcing of aseptic or sterile filling and finishing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Fill and Finish Outsourcing Market Report 2026?

The pharmaceutical fill and finish outsourcing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical fill and finish outsourcing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.